HHS-OIG – Page 2 – Policy & Medicine

HHS OIG Releases Data Brief with Updated Information on the Opioid Epidemic

HHS OIG Issues Advisory Opinion with Anti-Kickback Statute Reminders

HHS OIG Releases General Compliance Program Guidance

HHS OIG Starts to Enforce Information Blocking Penalties

HHS OIG Expands Enforcement Authority to Grant and Contract Fraud

Policy and Medicine Compliance Update October 2023 Issue Features: Complex World of Medical Education, FDA Regulation of Laboratory Developed Tests, FDA Post Marketing Requirements, Distinct Roles of Legal and Compliance and Teva’s Generic Price Fixing Settlement

HHS OIG Releases Semiannual Report to Congress

HHS OIG Publishes Final Rule on Information Blocking

HHS OIG Announces Changes to Compliance Program Guidance

Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations